Current processes for the production of recombinant adeno-associated virus (rAAV) are
inadequate to meet the surging demand for rAAV-based gene therapies. This article reviews …

Exosomes are gaining prominence as vectors for drug delivery, vaccination, and
regenerative medicine. Owing to their surface biochemistry, which reflects the parent cell …

Viral vectors are poised to acquire a prominent position in modern medicine and
biotechnology owing to their role as delivery agents for gene therapies, oncolytic agents …

The recent uptick in the approval of ex vivo cell therapies highlights the relevance of
lentivirus (LV) as an enabling viral vector of modern medicine. As labile biologics, however …

The increasing medical application of virus-like particles (VLPs), notably vaccines and viral
vectors, has increased the demand for commercial VLP production. However, VLP …

Adeno‐associated viruses (AAVs) have acquired a central role in modern medicine as
delivery agents for gene therapies targeting rare diseases. While new AAVs with improved …

Adenovirus (AdVs) is the viral vector of choice in vaccines and oncolytic applications owing
to its high transduction activity and inherent immunogenicity. For decades, AdV isolation has …

Traditional chromatography often faces issues such as high cost and insufficient selectivity,
driving a continuous demand for improved technologies. Current chromatography primarily …

Adeno-associated viruses (AAVs) have emerged as promising tools for gene therapy due to
their safety and efficacy in delivering therapeutic genes or gene editing sequences to …

The growth of biologics in modern medicine poses a pressing need for efficient process
technologies capable of delivering clinically relevant amounts of highly pure and active …